Wenzhou Kangning Hospital Co., Ltd.
HKEX:2120.HK
12.66 (HKD) • At close November 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 1,596.266 | 1,484.903 | 1,297.43 | 1,031.284 | 860.692 | 745.972 | 666.436 | 415.408 | 343.674 | 296.296 | 226.363 | 170.813 |
Cost of Revenue
| 1,185.13 | 1,131.972 | 968.432 | 728.702 | 656.185 | 493.73 | 449.332 | 273.24 | 213.289 | 181.313 | 140.273 | 112.209 |
Gross Profit
| 411.136 | 352.931 | 328.998 | 302.582 | 204.507 | 252.242 | 217.104 | 142.168 | 130.385 | 114.983 | 86.09 | 58.604 |
Gross Profit Ratio
| 0.258 | 0.238 | 0.254 | 0.293 | 0.238 | 0.338 | 0.326 | 0.342 | 0.379 | 0.388 | 0.38 | 0.343 |
Reseach & Development Expenses
| 32.466 | 33.028 | 27.962 | 20.973 | 6.018 | 5.733 | 1.574 | 2.877 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 198.941 | 59.293 | 41.315 | 125.062 | 123.339 | 98.001 | 91.754 | 78.531 | 62.52 | 45.611 | 32.31 | 28.326 |
Selling & Marketing Expenses
| 17.076 | 15.004 | 10.432 | 8.072 | 7.978 | 5.142 | 1.752 | 3.144 | 1.97 | 2.092 | 4.879 | 2.607 |
SG&A
| 68.555 | 74.297 | 51.747 | 133.135 | 131.317 | 103.143 | 93.506 | 81.675 | 64.49 | 47.703 | 38.993 | 31.147 |
Other Expenses
| 0 | 136.592 | 126.829 | -3.91 | -3.098 | -0.319 | -1.625 | -0.204 | -0.009 | -0.03 | 0 | 0 |
Operating Expenses
| 309.684 | 243.917 | 206.538 | 150.197 | 134.236 | 99.344 | 99.646 | 73.107 | 61.416 | 47.014 | 34.027 | 30.27 |
Operating Income
| 101.452 | 101.413 | 92.505 | 140.958 | 73.617 | 105.77 | 73.25 | 78.017 | 68.825 | 67.818 | 51.783 | 28.44 |
Operating Income Ratio
| 0.064 | 0.068 | 0.071 | 0.137 | 0.086 | 0.142 | 0.11 | 0.188 | 0.2 | 0.229 | 0.229 | 0.166 |
Total Other Income Expenses Net
| -2.27 | -67.492 | 3.186 | -17.667 | -18.094 | -20.732 | -37.977 | 14.122 | 1.345 | 0.749 | -4.207 | -10.476 |
Income Before Tax
| 99.182 | 15.605 | 95.704 | 87.904 | 55.523 | 106.91 | 69.863 | 92.139 | 70.17 | 68.567 | 47.576 | 17.964 |
Income Before Tax Ratio
| 0.062 | 0.011 | 0.074 | 0.085 | 0.065 | 0.143 | 0.105 | 0.222 | 0.204 | 0.231 | 0.21 | 0.105 |
Income Tax Expense
| 12.25 | 26.574 | 54.831 | 28.949 | 17.295 | 31.941 | 22.027 | 26.588 | 18.548 | 17.369 | 11.383 | 4.733 |
Net Income
| 85.948 | -10.969 | 44.036 | 55.77 | 38.228 | 80.596 | 49.071 | 68.832 | 55.709 | 51.198 | 36.193 | 13.231 |
Net Income Ratio
| 0.054 | -0.007 | 0.034 | 0.054 | 0.044 | 0.108 | 0.074 | 0.166 | 0.162 | 0.173 | 0.16 | 0.077 |
EPS
| 1.15 | -0.15 | 0.61 | 0.77 | 0.52 | 1.1 | 0.67 | 0.94 | 1.03 | 0.73 | 0.78 | 0.37 |
EPS Diluted
| 1.15 | -0.15 | 0.59 | 0.75 | 0.52 | 1.1 | 0.67 | 0.94 | 1.03 | 0.73 | 0.78 | 0.37 |
EBITDA
| 252.668 | 174.965 | 211.315 | 189.387 | 155.786 | 160.119 | 104.564 | 115.009 | 95.406 | 83.162 | 63.467 | 35.968 |
EBITDA Ratio
| 0.158 | 0.145 | 0.163 | 0.222 | 0.173 | 0.242 | 0.182 | 0.299 | 0.278 | 0.281 | 0.28 | 0.211 |